GRND vs GSK · rev $268.1M vs P/E 13, $103.31B cap
Grindr Inc (GRND) versus GlaxoSmithKline PLC ADR (GSK) — a side-by-side from cached financials, not a winner call.
Grindr Inc (GRND) is a software - application company listed on US.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Latest reported GRND revenue for 2026-06-30 was $268.1M. Net income was $44.5M. GRND currently screens at market cap $4.45B.
GSK does not have a complete income-statement cache yet.
GRND currently screens at market cap $4.45B. GSK currently screens at market cap $103.31B and trailing P/E 13.5.
Not investment advice. Open the GRND and GSK stock pages for the full models.
Not investment advice.